ClinicalTrials.govpublic full text
Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus
systemic lupus erythematosus, lupus, monoclonal antibody, b-cell immunotherapy, epratuzumab, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 885860
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.